컴퓨터 단층촬영(CT) 유도 생검 시장 보고서(2026년)

Computed tomography (CT)-guided biopsy is a minimally invasive diagnostic procedure that uses real-time computed tomography imaging to precisely direct a needle into specific target areas within the body for the collection of tissue samples. This method allows accurate localization of lesions in complex or difficult-to-access anatomical regions, enhancing diagnostic precision while minimizing harm to surrounding healthy tissues. It is commonly applied to assess abnormalities such as tumors, infections, and inflammatory conditions by enabling detailed histopathological evaluation.

The primary biopsy techniques used in CT-guided biopsy include core needle biopsy, fine needle aspiration biopsy, vacuum-assisted biopsy, and trephine or bone biopsy. Core needle biopsy is a minimally invasive technique in which a hollow needle is guided by computed tomography imaging to obtain a cylindrical tissue sample for comprehensive pathological analysis. These procedures are commonly performed on target organs such as the lungs, liver, kidneys, bones, pancreas, and other anatomical sites. The procedures utilize several computed tomography modalities, including conventional computed tomography, computed tomography fluoroscopy, cone-beam computed tomography, and spectral or dual-energy computed tomography. Different needle systems employed in these biopsies include coaxial, non-coaxial, semi-automated, and fully automated systems. The key end users comprise hospitals, imaging centers, and ambulatory surgical centers.

Tariffs are affecting the computed tomography (CT)-guided biopsy market by increasing the expenses associated with imported imaging systems, biopsy needles, contrast agents, and precision-guided interventional accessories utilized in diagnostic procedures. This is driving up overall procedure costs and impacting procurement budgets, particularly in import-dependent regions such as Asia-Pacific and Latin America where advanced radiology equipment is primarily sourced from international manufacturers. Segments such as CT modalities and automated needle systems are the most impacted due to their dependence on high-precision imported components. However, tariffs are also promoting local manufacturing of medical imaging consumables, regional supply chain diversification, and greater investment in domestic radiology infrastructure, which are enhancing long-term accessibility and cost resilience.

The computed tomography (CT)-guided biopsy market research report is one of a series of new reports from The Business Research Company that provides computed tomography (CT)-guided biopsy market statistics, including computed tomography (CT)-guided biopsy industry global market size, regional shares, competitors with a computed tomography (CT)-guided biopsy market share, detailed computed tomography (CT)-guided biopsy market segments, market trends and opportunities, and any further data you may need to thrive in the computed tomography (CT)-guided biopsy industry. This computed tomography (CT)-guided biopsy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The computed tomography (CT)-guided biopsy market size has grown strongly in recent years. It will grow from $0.77 billion in 2025 to $0.82 billion in 2026 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rising global cancer incidence, increasing adoption of imaging-based diagnostics, expansion of hospital radiology infrastructure, growing preference for minimally invasive procedures, improved availability of ct imaging systems.

The computed tomography (CT)-guided biopsy market size is expected to see strong growth in the next few years. It will grow to $1.06 billion by 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to increasing demand for early-stage cancer detection, rising adoption of precision medicine-based diagnostics, expansion of outpatient diagnostic centers, growing aging population requiring diagnostic interventions, advancements in biopsy needle technologies and procedural safety. Major trends in the forecast period include increasing adoption of minimally invasive diagnostic procedures for early and accurate disease detection, rising demand for image-guided precision interventions in oncology and infection diagnosis, growing preference for outpatient and ambulatory biopsy procedures to reduce hospital burden, expansion of interventional radiology departments improving access to ct-guided procedures, increasing focus on early cancer screening and tissue-based diagnostics in clinical workflows.

The increasing incidence of cancer is expected to propel the growth of the CT-guided biopsy market going forward. The rise in cancer cases is primarily contributing to market expansion, driven by an expanding aging population, as older individuals face a higher risk of developing solid tumors that require accurate and timely diagnostic confirmation. CT-guided biopsy supports this requirement by enabling precise tissue sampling from deep-seated or anatomically complex lesions, particularly in organs such as the lung, liver, pancreas, kidney, and bone, where imaging alone is often insufficient for definitive diagnosis and treatment planning. For instance, in April 2024, according to the International Agency for Research on Cancer, a France-based intergovernmental organization forming part of the World Health Organization, there were approximately 20 million new cancer cases and nearly 10 million cancer-related deaths globally in 2022. Demographic projections indicate that the annual number of new cancer cases is expected to reach 35 million by 2050, representing a 77% increase compared to 2022. Therefore, the rising incidence of cancer is supporting and propelling the growth of the CT-guided biopsy market.

Leading companies operating in the CT-guided biopsy market are focusing on the development of advanced navigation technologies, such as real-time CT navigation systems, to enhance procedural accuracy, reduce radiation exposure, and improve workflow efficiency. Real-time CT navigation systems are integrated imaging and guidance platforms that utilize 3D visualization and electromagnetic tracking to assist clinicians in accurately guiding biopsy needles to target lesions while minimizing the need for repeated imaging. For example, in April 2023, GE HealthCare, a US-based medical technology company, introduced its CT-Navigation solution. The system provides real-time 3D CT imaging for stereotactic needle guidance across procedures such as biopsies, ablations, and drainage. It incorporates electromagnetic navigation technology that enables complex needle trajectories, allowing clinicians to avoid critical anatomical structures. Additionally, the solution reduces radiation dose and procedure time by minimizing the need for multiple control scans while improving targeting accuracy, thereby enhancing safety and efficiency in interventional procedures.

In April 2023, GE HealthCare, a United States-based medical technology company, acquired IMACTIS for an undisclosed amount. Through this acquisition, GE HealthCare enhanced its interventional guidance capabilities by integrating CT-based needle navigation technology to improve procedural accuracy, workflow efficiency, and radiation management. IMACTIS is a France-based provider of CT-guided interventional navigation solutions for minimally invasive procedures.

Major companies operating in the computed tomography (ct)-guided biopsy market are Samsung Electronics, F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Stryker Corporation, Medtronic PLC, Boston Scientific Inc., Becton Dickinson and Company, Siemens Healthineers, Agilent Technologies Inc., GE HealthCare Technologies, Canon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Fujifilm Corporation, Illumina Inc., Koninklijke Philips N. V., Olympus Corporation, Hologic Inc., Teleflex Incorporated, Sysmex Corporation, QIAGEN N. V., Bio-Rad Laboratories Inc., Shimadzu Corporation, Merit Medical Systems Inc., Guerbet (GBT. PA)

North America was the largest region in the CT-guided biopsy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the computed tomography (CT)-guided biopsy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the computed tomography (CT)-guided biopsy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The CT-guided biopsy market includes revenues earned by entities by providing services such as ultrasound-guided biopsy, MRI-guided biopsy, stereotactic biopsy, fluoroscopy-guided biopsy, image-guided fine needle aspiration, core needle biopsy services, and interventional radiology biopsy. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Computed Tomography (CT)-Guided Biopsy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses computed tomography (ct)-guided biopsy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for computed tomography (ct)-guided biopsy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The computed tomography (ct)-guided biopsy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Biopsy Technique: Core Needle Biopsy; Fine Needle Aspiration; Vacuum-Assisted; Trephine Or Bone
• 2) By Target Organ: Lung; Liver; Kidney; Bone; Pancreas; Other Target Organs
• 3) By CT Modality: Conventional CT; CT-Fluoroscopy; Cone-Beam CT; Spectral Or Dual-Energy CT
• 4) By Needle System: Coaxial Systems; Non-Coaxial; Semi-Automated; Fully Automated
• 5) By End User: Hospitals; Imaging Centers; Ambulatory Surgical Centers
• Subsegments:
• 1) By Core Needle Biopsy: Automated Core Needle Biopsy; Image Guided Core Needle Biopsy; Coaxial Core Needle Biopsy; Single Use Core Needle Biopsy
• 2) By Fine Needle Aspiration: Image Guided Fine Needle Aspiration; Endoscopic Fine Needle Aspiration; Percutaneous Fine Needle Aspiration; Ultrasound Assisted Fine Needle Aspiration
• 3) By Vacuum-Assisted: Image Guided Vacuum-Assisted Biopsy; Stereotactic Vacuum-Assisted Biopsy; Ultrasound Guided Vacuum-Assisted Biopsy; High Volume Vacuum-Assisted Biopsy
• 4) By Trephine Or Bone: Bone Marrow Trephine Biopsy; Image Guided Bone Biopsy; Percutaneous Bone Biopsy; Orthopedic Bone Biopsy
• Companies Mentioned: Samsung Electronics; F. Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Stryker Corporation; Medtronic PLC; Boston Scientific Inc.; Becton Dickinson and Company; Siemens Healthineers; Agilent Technologies Inc.; GE HealthCare Technologies; Canon Inc.; Zimmer Biomet Holdings Inc.; Terumo Corporation; Fujifilm Corporation; Illumina Inc.; Koninklijke Philips N.V.; Olympus Corporation; Hologic Inc.; Teleflex Incorporated; Sysmex Corporation; QIAGEN N.V.; Bio-Rad Laboratories Inc.; Shimadzu Corporation; Merit Medical Systems Inc.; Guerbet (GBT.PA)
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Computed Tomography (CT)-Guided Biopsy Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Computed Tomography (CT)-Guided Biopsy Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Computed Tomography (CT)-Guided Biopsy Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Computed Tomography (CT)-Guided Biopsy Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Artificial Intelligence & Autonomous Intelligence
  • 4.1.2 Robotics & Autonomous Systems
  • 4.1.3 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.5 Biotechnology, Genomics & Precision Medicine
• 4.2. Major Trends
  • 4.2.1 Increasing Adoption Of Minimally Invasive Diagnostic Procedures For Early And Accurate Disease Detection
  • 4.2.2 Rising Demand Of Image-Guided Precision Interventions In Oncology And Infection Diagnosis
  • 4.2.3 Growing Preference For Outpatient And Ambulatory Biopsy Procedures To Reduce Hospital Burden
  • 4.2.4 Expansion Of Interventional Radiology Departments Improving Access To Ct-Guided Procedures
  • 4.2.5 Increasing Focus On Early Cancer Screening And Tissue-Based Diagnostics In Clinical Workflows

5. Computed Tomography (CT)-Guided Biopsy Market Analysis Of End Use Industries

• 5.1 Hospitals
• 5.2 Imaging Centers
• 5.3 Ambulatory Surgical Centers
• 5.4 Specialty Diagnostic Clinics
• 5.5 Research And Academic Medical Institutions

6. Computed Tomography (CT)-Guided Biopsy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Computed Tomography (CT)-Guided Biopsy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Computed Tomography (CT)-Guided Biopsy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Computed Tomography (CT)-Guided Biopsy Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Computed Tomography (CT)-Guided Biopsy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Computed Tomography (CT)-Guided Biopsy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Computed Tomography (CT)-Guided Biopsy Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Computed Tomography (CT)-Guided Biopsy Market Segmentation

• 9.1. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Core Needle Biopsy, Fine Needle Aspiration, Vacuum-Assisted, Trephine Or Bone
• 9.2. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Target Organ, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Lung, Liver, Kidney, Bone, Pancreas, Other Target Organs
• 9.3. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Conventional CT, CT-Fluoroscopy, Cone-Beam CT, Spectral Or Dual-Energy CT
• 9.4. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Needle System, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Coaxial Systems, Non-Coaxial, Semi-Automated, Fully Automated
• 9.5. Global Computed Tomography (CT)-Guided Biopsy Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Hospitals, Imaging Centers, Ambulatory Surgical Centers
• 9.6. Global Computed Tomography (CT)-Guided Biopsy Market, Sub-Segmentation Of Core Needle Biopsy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Automated Core Needle Biopsy, Image Guided Core Needle Biopsy, Coaxial Core Needle Biopsy, Single Use Core Needle Biopsy
• 9.7. Global Computed Tomography (CT)-Guided Biopsy Market, Sub-Segmentation Of Fine Needle Aspiration, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Image Guided Fine Needle Aspiration, Endoscopic Fine Needle Aspiration, Percutaneous Fine Needle Aspiration, Ultrasound Assisted Fine Needle Aspiration
• 9.8. Global Computed Tomography (CT)-Guided Biopsy Market, Sub-Segmentation Of Vacuum-Assisted, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Image Guided Vacuum-Assisted Biopsy, Stereotactic Vacuum-Assisted Biopsy, Ultrasound Guided Vacuum-Assisted Biopsy, High Volume Vacuum-Assisted Biopsy
• 9.9. Global Computed Tomography (CT)-Guided Biopsy Market, Sub-Segmentation Of Trephine Or Bone, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bone Marrow Trephine Biopsy, Image Guided Bone Biopsy, Percutaneous Bone Biopsy, Orthopedic Bone Biopsy

10. Computed Tomography (CT)-Guided Biopsy Market Regional And Country Analysis

• 10.1. Global Computed Tomography (CT)-Guided Biopsy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Computed Tomography (CT)-Guided Biopsy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Computed Tomography (CT)-Guided Biopsy Market

• 11.1. Asia-Pacific Computed Tomography (CT)-Guided Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Computed Tomography (CT)-Guided Biopsy Market

• 12.1. China Computed Tomography (CT)-Guided Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Computed Tomography (CT)-Guided Biopsy Market

• 13.1. India Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Computed Tomography (CT)-Guided Biopsy Market

• 14.1. Japan Computed Tomography (CT)-Guided Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Computed Tomography (CT)-Guided Biopsy Market

• 15.1. Australia Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Computed Tomography (CT)-Guided Biopsy Market

• 16.1. Indonesia Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Computed Tomography (CT)-Guided Biopsy Market

• 17.1. South Korea Computed Tomography (CT)-Guided Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Computed Tomography (CT)-Guided Biopsy Market

• 18.1. Taiwan Computed Tomography (CT)-Guided Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Computed Tomography (CT)-Guided Biopsy Market

• 19.1. South East Asia Computed Tomography (CT)-Guided Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Computed Tomography (CT)-Guided Biopsy Market

• 20.1. Western Europe Computed Tomography (CT)-Guided Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Computed Tomography (CT)-Guided Biopsy Market

• 21.1. UK Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Computed Tomography (CT)-Guided Biopsy Market

• 22.1. Germany Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Computed Tomography (CT)-Guided Biopsy Market

• 23.1. France Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Computed Tomography (CT)-Guided Biopsy Market

• 24.1. Italy Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Computed Tomography (CT)-Guided Biopsy Market

• 25.1. Spain Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Computed Tomography (CT)-Guided Biopsy Market

• 26.1. Eastern Europe Computed Tomography (CT)-Guided Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Computed Tomography (CT)-Guided Biopsy Market

• 27.1. Russia Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Computed Tomography (CT)-Guided Biopsy Market

• 28.1. North America Computed Tomography (CT)-Guided Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Computed Tomography (CT)-Guided Biopsy Market

• 29.1. USA Computed Tomography (CT)-Guided Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Computed Tomography (CT)-Guided Biopsy Market

• 30.1. Canada Computed Tomography (CT)-Guided Biopsy Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Computed Tomography (CT)-Guided Biopsy Market

• 31.1. South America Computed Tomography (CT)-Guided Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Computed Tomography (CT)-Guided Biopsy Market

• 32.1. Brazil Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Computed Tomography (CT)-Guided Biopsy Market

• 33.1. Middle East Computed Tomography (CT)-Guided Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Computed Tomography (CT)-Guided Biopsy Market

• 34.1. Africa Computed Tomography (CT)-Guided Biopsy Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Computed Tomography (CT)-Guided Biopsy Market, Segmentation By Biopsy Technique, Segmentation By Target Organ, Segmentation By CT Modality, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Computed Tomography (CT)-Guided Biopsy Market Regulatory and Investment Landscape

36. Computed Tomography (CT)-Guided Biopsy Market Competitive Landscape And Company Profiles

• 36.1. Computed Tomography (CT)-Guided Biopsy Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Computed Tomography (CT)-Guided Biopsy Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Computed Tomography (CT)-Guided Biopsy Market Company Profiles
  • 36.3.1. Samsung Electronics Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis

37. Computed Tomography (CT)-Guided Biopsy Market Other Major And Innovative Companies

• Boston Scientific Inc., Becton Dickinson and Company, Siemens Healthineers, Agilent Technologies Inc., GE HealthCare Technologies, Canon Inc., Zimmer Biomet Holdings Inc., Terumo Corporation, Fujifilm Corporation, Illumina Inc., Koninklijke Philips N.V., Olympus Corporation, Hologic Inc., Teleflex Incorporated, Sysmex Corporation

38. Global Computed Tomography (CT)-Guided Biopsy Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Computed Tomography (CT)-Guided Biopsy Market

41. Computed Tomography (CT)-Guided Biopsy Market High Potential Countries, Segments and Strategies

• 41.1 Computed Tomography (CT)-Guided Biopsy Market In 2030 - Countries Offering Most New Opportunities
• 41.2 Computed Tomography (CT)-Guided Biopsy Market In 2030 - Segments Offering Most New Opportunities
• 41.3 Computed Tomography (CT)-Guided Biopsy Market In 2030 - Growth Strategies
  • 41.3.1 Market Trend Based Strategies
  • 41.3.2 Competitor Strategies

42. Appendix

• 42.1. Abbreviations
• 42.2. Currencies
• 42.3. Historic And Forecast Inflation Rates
• 42.4. Research Inquiries
• 42.5. The Business Research Company
• 42.6. Copyright And Disclaimer